1 - 25 of 77 results for author:"Bergmann C." in Literature citations
Results Customize
› Repeat search in UniProtKB (397)
| Mutations in the prostaglandin transporter SLCO2A1 cause primary hypertrophic osteoarthropathy with digital clubbing. Busch J., Frank V., Bachmann N., Otsuka A., Oji V., Metze D., Shah K., Danda S., Watzer B., Traupe H. et al. J. Invest. Dermatol. 132:2473-2476(2012) · UniProtKB (1) · Mapped (3) |
| Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. Fensterl V., Wetzel J.L., Ramachandran S., Ogino T., Stohlman S.A., Bergmann C.C., Diamond M.S., Virgin H.W., Sen G.C. PLoS Pathog. 8:E1002712-E1002712(2012) · UniProtKB (1) · Mapped (2) |
| HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. Wild C.A., Bergmann C., Fritz G., Schuler P., Hoffmann T.K., Lotfi R., Westendorf A., Brandau S., Lang S. Int. Immunol. 24:485-494(2012) · Mapped (5) |
| Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Akhmetshina A., Palumbo K., Dees C., Bergmann C., Venalis P., Zerr P., Horn A., Kireva T., Beyer C., Zwerina J. et al. Nat Commun 3:735-735(2012) · Mapped (9) |
| Novel mutation in the glycoprotein Ibbeta in a patient with Bernard-Soulier syndrome: possibility of distant parental consanguinity. Mahfouz R.A., Bolz H.J., Otrock Z.K., Bergmann C., Muwakkit S. Blood Coagul. Fibrinolysis 23:335-337(2012) · Mapped (1) |
| HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer. Wild C.A., Brandau S., Lotfi R., Mattheis S., Gu X., Lang S., Bergmann C. Oral Oncol. 48:409-416(2012) · Mapped (5) |
| Heparin-induced leukocytosis requires 6-O-sulfation and is caused by blockade of selectin- and CXCL12 protein-mediated leukocyte trafficking in mice. Zhang S., Condac E., Qiu H., Jiang J., Gutierrez-Sanchez G., Bergmann C., Handel T., Wang L. J. Biol. Chem. 287:5542-5553(2012) · Mapped (18) |
| Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. Bergmann C., von Bothmer J., Ortiz Bruchle N., Venghaus A., Frank V., Fehrenbach H., Hampel T., Pape L., Buske A., Jonsson J. et al. J. Am. Soc. Nephrol. 22:2047-2056(2011) · Mapped (10) |
| Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck. Hoffmann T.K., Trellakis S., Okulicz K., Schuler P., Greve J., Arnolds J., Bergmann C., Bas M., Lang S., Lehnerdt G. et al. Anticancer Res. 31:3151-3157(2011) · Mapped (41) |
| Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells. Bergmann C., Wild C.A., Narwan M., Lotfi R., Lang S., Brandau S. Eur. J. Immunol. 41:3564-3573(2011) · Mapped (12) |
| Inhibition of glycogen synthase kinase 3beta induces dermal fibrosis by activation of the canonical Wnt pathway. Bergmann C., Akhmetshina A., Dees C., Palumbo K., Zerr P., Beyer C., Zwerina J., Distler O., Schett G., Distler J.H. Ann. Rheum. Dis. 70:2191-2198(2011) · Mapped (4) |
| MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis. Savarin C., Stohlman S.A., Rietsch A.M., Butchi N., Ransohoff R.M., Bergmann C.C. Glia 59:1770-1781(2011) · Mapped (4) |
| Disruption of a ciliary B9 protein complex causes Meckel syndrome. Dowdle W.E., Robinson J.F., Kneist A., Sirerol-Piquer M.S., Frints S.G., Corbit K.C., Zaghloul N.A., van Lijnschoten G., Mulders L., Verver D.E. et al. Am. J. Hum. Genet. 89:94-110(2011) · UniProtKB (4) · Mapped (77) |
| Primary hypertrophic osteoarthropathy with digital clubbing and palmoplantar hyperhidrosis caused by 15-PGHD/HPGD loss-of-function mutations. Bergmann C., Wobser M., Morbach H., Falkenbach A., Wittenhagen D., Lassay L., Ott H., Zerres K., Girschick H.J., Hamm H. Exp. Dermatol. 20:531-533(2011) · Mapped (3) |
| Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Becker J., Semler O., Gilissen C., Li Y., Bolz H.J., Giunta C., Bergmann C., Rohrbach M., Koerber F., Zimmermann K. et al. Am. J. Hum. Genet. 88:362-371(2011) · UniProtKB (1) |
| TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Davis E.E., Zhang Q., Liu Q., Diplas B.H., Davey L.M., Hartley J., Stoetzel C., Szymanska K., Ramaswami G., Logan C.V. et al. |
| Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis. Phares T.W., Stohlman S.A., Hinton D.R., Atkinson R., Bergmann C.C. J. Immunol. 185:5607-5618(2010) · Mapped (5) |
| Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Otto E.A., Hurd T.W., Airik R., Chaki M., Zhou W., Stoetzel C., Patil S.B., Levy S., Ghosh A.K., Murga-Zamalloa C.A. et al. |
| Genetic variation of DKK3 may modify renal disease severity in ADPKD. Liu M., Shi S., Senthilnathan S., Yu J., Wu E., Bergmann C., Zerres K., Bogdanova N., Coto E., Deltas C. et al. J. Am. Soc. Nephrol. 21:1510-1520(2010) · Mapped (9) |
| The mTOR pathway is activated in human autosomal-recessive polycystic kidney disease. Becker J.U., Opazo Saez A., Zerres K., Witzke O., Hoyer P.F., Schmid K.W., Kribben A., Bergmann C., Nurnberger J. Kidney Blood Press. Res. 33:129-138(2010) · Mapped (5) |
| Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Kang Z., Altuntas C.Z., Gulen M.F., Liu C., Giltiay N., Qin H., Liu L., Qian W., Ransohoff R.M., Bergmann C. et al. Immunity 32:414-425(2010) · Mapped (6) |
| Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2). Czystowska M., Strauss L., Bergmann C., Szajnik M., Rabinowich H., Whiteside T.L. |
| RNase L mediated protection from virus induced demyelination. Ireland D.D., Stohlman S.A., Hinton D.R., Kapil P., Silverman R.H., Atkinson R.A., Bergmann C.C. PLoS Pathog. 5:e1000602-e1000602(2009) · Mapped (5) |
| A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies. Khanna H., Davis E.E., Murga-Zamalloa C.A., Estrada-Cuzcano A., Lopez I., den Hollander A.I., Zonneveld M.N., Othman M.I., Waseem N., Chakarova C.F. et al. |
| Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. Phares T.W., Ramakrishna C., Parra G.I., Epstein A., Chen L., Atkinson R., Stohlman S.A., Bergmann C.C. J. Immunol. 182:5430-5438(2009) · Mapped (14) |